{"prompt": "['11 July 2019', 'ARGX-113-1704', 'ARGX-113', 'Protocol Version 3.0, Final', '18.', 'Muppidi, S., G. I. Wolfe, M. Conaway, et al. (2011). \"MG-ADL: still a relevant', 'outcome measure.\" Muscle Nerve 44(5): 727-731.', '19.', 'Nowak, R. J., D. B. Dicapua, N. Zebardast, et al. (2011). \"Response of patients with', 'refractory myasthenia gravis to rituximab: a retrospective study.\" Ther Adv Neurol', 'Disord 4(5): 259-266.', '20.', 'Patel, D. A., A. Puig-Canto, D. K. Challa, et al. (2011). \"Neonatal Fc receptor blockade', 'by Fc engineering ameliorates arthritis in a murine model.\" J Immunol 187(2): 1015-', '1022.', '21.', 'Roopenian, D. C. and S. Akilesh (2007). \"FcRn: the neonatal Fc receptor comes of', \"age.' Nat Rev Immunol 7(9): 715-725.\", '22.', 'Sadjadi, R., M. Conaway, G. Cutter, et al. (2012). \"Psychometric evaluation of the', 'myasthenia gravis composite using Rasch analysis.\" Muscle Nerve 45(6): 820-825.', '23.', 'Simon, G. E., C. M. Rutter, D. Peterson, et al. (2013). \"Does response on the PHQ-9', 'Depression Questionnaire predict subsequent suicide attempt or suicide death?\"', 'Psychiatr Serv 64(12): 1195-1202.', '24.', 'Vaccaro, C., J. Zhou, R. J. Ober, et al. (2005). \"Engineering the Fc region of', 'immunoglobulin G to modulate in vivo antibody levels.\" Nat Biotech 23(10): 1283-', '1288.', '25.', 'Vincent, A., B. Lang and K. A. Kleopa (2006). \"Autoimmune channelopathies and', 'related neurological disorders.\" Neuron 52(1): 123-138.', '26.', 'WHO. (2001). \"World Health Organization. International Classification of', 'Functioning, Disability, and Health (ICF). 1st edition. World Health Organization', '2001.\", from http://www.who.int/classifications/icf/en/.', '27.', 'Wolfe, G. I., L. Herbelin, S. P. Nations, et al. (1999). \"Myasthenia gravis activities of', \"daily living profile.' Neurology 52(7): 1487-1489.\", '28.', 'Wolfe, G. I., H. J. Kaminski and I. B. Aban, et al (2016). \"Randomized Trial of', 'Thymectomy in Myasthenia Gravis.\" N Engl J Med 375(6): 511-522.', 'argenx BVBA', 'Confidential', 'Page 100 of 110']['11 July 2019', 'ARGX-113-1704', 'ARGX-113', 'Protocol Version 3.0, Final', '13.', 'APPENDICES', 'Appendix 1 Myasthenia Gravis-Activities of Daily Living', 'Grade', '0', '1', '2', '3', 'Score', 'Talking', 'Normal Intermittent slurring', 'Constant slurring', \"Difficr' to\", 'or nasal speech', 'or nasal, but can be', 'und', 'and', 'understood', 'peech', 'Chewing', 'Normal', 'Fatigue with', 'Faticue with', 'tric', 'solid food', 'so. bod', 'Swallowing', 'Normal', 'Rare episode', \"ent c. 'ring\", 'Costric tube', 'of choking', 'ne sitati.', 'chat', 'es in die', 'Breathing', 'Normal', 'Shortness', 'breat,', 'S\u00b9', '.ness of breath', 'Ventilator', 'with e.', 'n', 'at rest', 'dependence', 'Impairment of ability to', 'None', 'Extra effort', 'but', 'Re', 'heriods needed', 'Cannot do one of', 'brush teeth or comb hair', '+', 'periods', 'edeu', 'these functions', 'Impairment of ability to', 'None', 'S.', 'til', 'S', 'Moderate,', 'Severe, requires', 'arise from a chair', '\"es arm.', 'always uses arms', 'assistance', 'Double vision', 'None', 'Oc rs,', 'Daily,', 'Constant', 'not daily', 'but not constant', 'F: .d droup', 'one', 'Occurs, but', 'Daily, but', 'Constant', 'not daily', 'not constant', 'Total score', 'Source: website MGFA, MG-ADL (Wolfe, Herbelin et al. 1999; Muppidi, Wolfe et al. 2011)', 'argenx BVBA', 'Confidential', 'Page 101 of 110']\n\n###\n\n", "completion": "END"}